Company profile · Oslo, Norway

Age Labs AS

Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection · Molecular diagnostics development

Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.

Lead
Andre Lovestam (verified ↗)
Address
Gaustadalleen 23A, 0373 Oslo, Norway (source ↗)
Compliance
Not yet on record
Last reviewed
24 Apr 2026 (1mo ago)
Scale
Molecular diagnostics development
Capabilities
DNA Methylation Biomarker Discovery · Machine-Learning Biobank Analytics · Early Rheumatoid Arthritis Diagnostic
Founded
2021
Headcount
1-10
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Andre Lovestam

Chief Executive Officer

Check official leadership source
Full addressGaustadalleen 23A, 0373 Oslo, Norway
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

Norway Health Tech member profile listing Age Labs at Gaustadalleen 23A, Oslo.

Open source
Operating profile

Molecular diagnostics development

Oslo, Norway. Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection. Review completed on 24 Apr 2026.

2026 technical specializationEpigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection
Core capabilities
DNA Methylation Biomarker DiscoveryMachine-Learning Biobank AnalyticsEarly Rheumatoid Arthritis Diagnostic
Governance

Norwegian Medicines Agency and EU IVDR for future clinical diagnostic launches

Public CEO disclosure, Norway Health Tech member profile, Biomarker development pipeline

Editorial note

Epigenetic Diagnostics, DNA Methylation Biomarkers, and Early-Disease Detection

Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program.

Editorial note

Age Labs is an Oslo molecular diagnostics startup translating epigenetic biobank data into early-detection tests, with a named CEO, a rheumatoid arthritis lead program, and Norway Health Tech member recognition.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

DNA Methylation Biomarker Discovery
Machine-Learning Biobank Analytics
Early Rheumatoid Arthritis Diagnostic
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceAge Labs news post confirming Andre Lovestam as Chief Executive Officer.Source origin: agelabs.comOpen source
Supporting evidenceAge Labs team page with current leadership listing.Source origin: agelabs.comOpen source
Physical-site evidenceNorway Health Tech member profile listing Age Labs at Gaustadalleen 23A, Oslo.Source origin: norwayhealthtech.comOpen source
Infrastructure

Declared infrastructure

Methylation biomarker assay workflow
Biobank analytics
Clinical-validation partnerships
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Age Labs AS located?
Age Labs AS operates from Gaustadalleen 23A, 0373 Oslo, Norway, Oslo, Norway.
Who runs Age Labs AS?
Age Labs AS is led by Andre Lovestam, Chief Executive Officer. Verified 24 Apr 2026.
What does Age Labs AS do?
Oslo molecular diagnostics startup with named CEO, epigenetic biomarker focus, and a lead rheumatoid arthritis early-detection program. Core capabilities: DNA Methylation Biomarker Discovery, Machine-Learning Biobank Analytics, Early Rheumatoid Arthritis Diagnostic.
Editorial context

Related technical briefs

Briefs that name Oslo as a covered market or city.